全文获取类型
收费全文 | 1216篇 |
免费 | 64篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 24篇 |
妇产科学 | 18篇 |
基础医学 | 185篇 |
口腔科学 | 49篇 |
临床医学 | 107篇 |
内科学 | 186篇 |
皮肤病学 | 10篇 |
神经病学 | 97篇 |
特种医学 | 11篇 |
外科学 | 192篇 |
综合类 | 36篇 |
预防医学 | 162篇 |
眼科学 | 10篇 |
药学 | 72篇 |
1篇 | |
中国医学 | 10篇 |
肿瘤学 | 107篇 |
出版年
2024年 | 8篇 |
2023年 | 16篇 |
2022年 | 22篇 |
2021年 | 55篇 |
2020年 | 34篇 |
2019年 | 42篇 |
2018年 | 47篇 |
2017年 | 29篇 |
2016年 | 35篇 |
2015年 | 36篇 |
2014年 | 42篇 |
2013年 | 63篇 |
2012年 | 85篇 |
2011年 | 97篇 |
2010年 | 50篇 |
2009年 | 49篇 |
2008年 | 55篇 |
2007年 | 75篇 |
2006年 | 54篇 |
2005年 | 75篇 |
2004年 | 49篇 |
2003年 | 51篇 |
2002年 | 61篇 |
2001年 | 19篇 |
2000年 | 8篇 |
1999年 | 12篇 |
1998年 | 15篇 |
1997年 | 7篇 |
1996年 | 5篇 |
1995年 | 6篇 |
1994年 | 2篇 |
1993年 | 8篇 |
1992年 | 12篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1988年 | 5篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1978年 | 5篇 |
1974年 | 2篇 |
1954年 | 1篇 |
1946年 | 1篇 |
1934年 | 1篇 |
1933年 | 1篇 |
排序方式: 共有1282条查询结果,搜索用时 15 毫秒
41.
42.
Ishii N Yoshida S Yoshinaga A Ohno R Terao T Watanabe T Hayashi T Yamada T 《Hinyokika kiyo. Acta urologica Japonica》2006,52(2):159-161
A 33-year-old man referred to our hospital with a painful swelling of the left scrotal content which had gradually enlarged during the past 4 years. Physical examination revealed a hard, irregular, nontender mass of 5x4 cm in the left scrotum. The mass was fixed to the left epididymis and spermatic cord. Local excision was performed and histologcal examination revealed leiomyosarcoma originating from the spermatic cord. Distant metastases were not observed. Because of the reportedly high propensity for local recurrence, we performed radical orchiectomy and adjuvant radiation. The patient has been alive for 13 months with no evidence of disease. 相似文献
43.
David C. Perry Rena Getz Ivan Y. Lee David Panchison Yasuharu Okuda Leonard P. Miller 《Brain research》1993,617(2)
Transient forebrain ischemia was produced in gerbils by short-term occlusion of the common carotid arteries under halothane anesthesia. Histological analysis of brains 7 days post-ischemia demonstrated characteristic destruction of CA1 pyramidal cells. λ Opiate binding (measured with [3H]naloxone in the presence of 300 nM diprenorphine) at 7 days post-ischemia was significantly increased in the stratum lucidum of the hippocampus (the mossy fiber layer), but not in any other region measured, including other hippocampal regions, cortex, amygdala, caudate putamen, thalamus, and hypothalamus. The increase in mossy fiber λ binding was slow to develop (no increase detected up to 48 h post-ischemia), and long-lasting (binding remained elevated at 32 days post-ischemia). While MK-801 significantly inhibited CA1 pyramidal cell destruction when administered 20 min prior to ischemia, the increase in mossy fiber λ binding was still evident. None of seven different opioid agonists and antagonists examined had an effect on either the pyramidal cell damage or increased mossy fiber λ binding seen 7 days after ischemia. 相似文献
44.
This study examined linkages between divorce, depressive/withdrawn parenting, and child adjustment problems at home and school. Middle class divorced single mother families (n=35) and 2-parent families (n=174) with a child in the fourth grade participated. Mothers and teachers completed yearly questionnaires and children were interviewed when they were in the fourth, fifth, and sixth grades. Structural equation modeling suggested that the association between divorce and child externalizing and internalizing behavior was partially mediated by depressive/withdrawn parenting when the children were in the fourth and fifth gradesThis study was supported by a grant (R29-48595) from the National Institute of Mental Health awarded to Rena Repetti; Jeffrey Wood was supported by a training grant from the National Institute of Mental Health (Biobehavioral Issues in Physical and Mental Health; MH15750) and a UCLA Research Fellowship. We are very grateful to the children, teachers, and school administrators who participated in the study, and to the many research assistants who helped to collect the data. 相似文献
45.
Sayeh S. Nikpay PhD MPH Melinda B. Buntin PhD Rena M. Conti 《Health services research》2020,55(2):157-169
46.
Eo Toriyama Tomoko Hata Kenichi Yokota Masahiko Chiwata Rena Kamijo Miki Hashimoto Masataka Taguchi Makiko Horai Masatoshi Matsuo Emi Matsuo Yumi Takasaki Yasuhisa Kawaguchi Hidehiro Itonaga Shinya Sato Koji Ando Yasushi Sawayama Jun Taguchi Yoshitaka Imaizumi Hideki Tsushima Tatsuro Jo Shinichiro Yoshida Yukiyoshi Moriuchi Yasushi Miyazaki 《Cancer science》2020,111(12):4490
The efficacy of azacitidine (AZA) on survival of lower risk (LR) ‐ myelodysplastic syndromes (MDS) is controversial. To address this issue, we retrospectively evaluated the long‐term survival benefit of AZA for patients with LR‐MDS defined by International Prognostic Scoring System (IPSS). Using data from 489 patients with LR‐MDS in Nagasaki, hematologic responses according to International Working Group 2006 and overall survival (OS) were compared among patients that received best supportive care (BSC), immunosuppressive therapy (IST), erythropoiesis‐stimulating agents (ESA), and AZA. Patients treated with AZA showed complete remission (CR) rate at 11.3%, marrow CR at 1.9%, and any hematologic improvement at 34.0%, with transfusion independence (TI) of red blood cells in 27.3% of patients. and platelet in 20% of patients, respectively. Median OS for patients received IST, ESA, BSC, and AZA (not reached, 91 months, 58 months, and 29 months, respectively) differed significantly (P < .001). Infection‐related severe adverse events were observed in more than 20% of patients treated with AZA. Multivariate analysis showed age, sex, IPSS score at diagnosis, and transfusion dependence were significant for OS, but AZA treatment was not, which maintained even response to AZA, and IPSS risk status at AZA administration was added as factors. We could not find significant survival benefit of AZA treatment for LR‐MDS patients. 相似文献
47.
48.
Frank A. J. L. Scheer Michael F. Hilton Heather L. Evoniuk Sally A. Shiels Atul Malhotra Rena Sugarbaker R. Timothy Ayers Elliot Israel Anthony F. Massaro Steven A. Shea 《Proceedings of the National Academy of Sciences of the United States of America》2021,118(37)
Asthma often worsens at night. To determine if the endogenous circadian system contributes to the nocturnal worsening of asthma, independent of sleep and other behavioral and environmental day/night cycles, we studied patients with asthma (without steroid use) over 3 wk in an ambulatory setting (with combined circadian, environmental, and behavioral effects) and across the circadian cycle in two complementary laboratory protocols performed in dim light, which separated circadian from environmental and behavioral effects: 1) a 38-h “constant routine,” with continuous wakefulness, constant posture, 2-hourly isocaloric snacks, and 2) a 196-h “forced desynchrony” incorporating seven identical recurring 28-h sleep/wake cycles with all behaviors evenly scheduled across the circadian cycle. Indices of pulmonary function varied across the day in the ambulatory setting, and both laboratory protocols revealed significant circadian rhythms, with lowest function during the biological night, around 4:00 AM, uncovering a nocturnal exacerbation of asthma usually unnoticed or hidden by the presence of sleep. We also discovered a circadian rhythm in symptom-based rescue bronchodilator use (β2-adrenergic agonist inhaler) whereby inhaler use was four times more likely during the circadian night than day. There were additive influences on asthma from the circadian system plus sleep and other behavioral or environmental effects. Individuals with the lowest average pulmonary function tended to have the largest daily circadian variations and the largest behavioral cycle effects on asthma. When sleep was modeled to occur at night, the summed circadian, behavioral/environmental cycle effects almost perfectly matched the ambulatory data. Thus, the circadian system contributes to the common nocturnal worsening of asthma, implying that internal biological time should be considered for optimal therapy.Asthma is characterized by bronchial hyperreactivity leading to airway inflammation, bronchoconstriction, and symptoms of “chest tightness.” It has been recognized for hundreds of years that asthma severity generally increases at night, producing what had historically been termed “nocturnal asthma.” For instance, in 1698, the physician Sir John Floyer recognized from his own experience that “at first waking, about one or two of the Clock in the Night, the Fit of the Asthma more evidently begins” (1). Nocturnal worsening of asthma occurs in as many as 75% of patients with asthma, equating to 20 million people in the United States alone (2–6). The variation across the day and night in peak expiratory flow (PEF) can be as much as 50% (7, 8). Also, the highest rate of asthma exacerbations leading to respiratory failure or death occurs across the night (3, 9, 10). Therefore, understanding the mechanisms underlying the daily variability in asthma severity could have major diagnostic and therapeutic implications.Behavioral and environmental factors are known to affect asthma severity, including exercise, air temperature, pollution, the sleep/wake cycle (11), changes in posture (12), and the sleeping environment (13). However, it is also possible that the endogenous circadian timing system contributes to nocturnal worsening of asthma (14). The circadian system—composed of the central circadian pacemaker in the suprachiasmatic nucleus of the hypothalamus and circadian oscillators in most organs and tissues of the body—orchestrates ∼24-h rhythms in physiology and behavior (15). This endogenous timing system may influence the pulmonary and inflammatory system via the autonomic nervous system (16), humoral factors (17), and/or local molecular clocks (18, 19).We tested the hypothesis that the circadian system, independent of sleep and other behavioral and environmental factors, contributes to the nocturnal worsening of asthma in humans. 相似文献
49.
50.